Outset Medical, Inc.

NasdaqGS:OM Stock Report

Market Cap: US$130.8m

Outset Medical Past Earnings Performance

Past criteria checks 0/6

Outset Medical's earnings have been declining at an average annual rate of -24.1%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 37.6% per year.

Key information

-24.1%

Earnings growth rate

91.2%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate37.6%
Return on equity-140.6%
Net Margin-132.5%
Next Earnings Update08 May 2024

Recent past performance updates

Recent updates

Not Many Are Piling Into Outset Medical, Inc. (NASDAQ:OM) Stock Yet As It Plummets 29%

Feb 14
Not Many Are Piling Into Outset Medical, Inc. (NASDAQ:OM) Stock Yet As It Plummets 29%

Outset Medical, Inc.'s (NASDAQ:OM) Earnings Haven't Escaped The Attention Of Investors

Jun 09
Outset Medical, Inc.'s (NASDAQ:OM) Earnings Haven't Escaped The Attention Of Investors

Outset Medical: Tablo Ship Hold A Key Overhang To Unlock Risk Capital

Sep 20

Outset Medical awarded VA contract for hemodialysis

Aug 15

Outset Medical jumps 24% after 2Q results as FDA clears hemodialysis system

Aug 01

Outset Medical: Margins Leave No Tangible Value Flow, Pricing 18% Downside

Jul 06

Outset Medical Grows Revenue But Operating Losses Remain High

Dec 29

Revenue & Expenses Breakdown
Beta

How Outset Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:OM Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23130-17314157
30 Sep 23132-17614356
30 Jun 23129-17013853
31 Mar 23118-17013652
31 Dec 22115-16313049
30 Sep 22112-16312949
30 Jun 22110-15212045
31 Mar 22110-13910940
31 Dec 21103-13210137
30 Sep 2192-1239333
30 Jun 2179-1359633
31 Mar 2166-1318731
31 Dec 2050-797629
30 Sep 2040-676028
30 Jun 2029-414224
31 Mar 2020-403424
31 Dec 1915-852923
31 Dec 182-731823

Quality Earnings: OM is currently unprofitable.

Growing Profit Margin: OM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: OM is unprofitable, and losses have increased over the past 5 years at a rate of 24.1% per year.

Accelerating Growth: Unable to compare OM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).


Return on Equity

High ROE: OM has a negative Return on Equity (-140.62%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.